Biosynthesis of the tunicamycin antibiotics proceeds via unique exo-glycal intermediates. (2012)
Attributed to:
Understanding and Exploiting Tunicamycin (Bio)Synthesis to Enable Novel Antibiotics and Inhibitors
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/nchem.1351
PubMed Identifier: 22717438
Publication URI: http://europepmc.org/abstract/MED/22717438
Type: Journal Article/Review
Volume: 4
Parent Publication: Nature chemistry
Issue: 7
ISSN: 1755-4330